drugset / Trial / NCT00337506

Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

NCT00337506 ↗

Phase 2 Terminated 50 enrolled Nantes University Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the efficacy and safety of Velcade plus dexamethasone used as induction chemotherapy prior to autologous transplantation.

Timeline

Start
2003-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bortezomib Small molecule — —
Subject Dexamethasone Small molecule — —

Indications